Real-world Incidence of Intraocular Inflammation Following Intravitreal Faricimab Therapy
NCT06902207
·
clinicaltrials.gov ↗
COMPLETED
Status
6053
Enrollment
OTHER
Sponsor class
Conditions
Intraocular Inflammation
Interventions
DRUG:
Faricimab Injection [Vabysmo]
Sponsor
Rigshospitalet, Denmark